| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $3.6B | $3.3B | $3.7B | $2.4B | $0.8B | $0.6B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.4B | $0.9B | $0.4B | $1.0B | $0.4B | $0.4B | $0.2B | $0.2B |
| Net Income | $-0.1B | $0.4B | $-0.1B | $0.5B | $0.1B | $0.4B | $0.2B | $0.1B |
| EPS (Basic) | $-1.41 | $3.40 | $-1.39 | $4.38 | $0.40 | $2.24 | $0.82 | $1.01 |
| EPS (Diluted) | $-1.41 | $3.36 | $-1.39 | $4.33 | $0.40 | $2.22 | $0.81 | $1.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.4B | $10.5B | $10.6B | $11.2B | $11.1B | $7.6B | $7.0B | $4.2B |
| Current Assets | $0.7B | $0.5B | $0.5B | $0.9B | $1.0B | $1.3B | $0.7B | $0.9B |
| Cash & Equivalents | $0.4B | $0.1B | $0.0B | $0.1B | $0.2B | $0.8B | $0.2B | $0.7B |
| Total Liabilities | $7.6B | $7.6B | $8.0B | $8.4B | $8.7B | $5.2B | $4.9B | $3.0B |
| Current Liabilities | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B |
| Stockholders' Equity | $2.2B | $2.3B | $2.0B | $2.1B | $1.8B | $1.8B | $1.5B | $1.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.8B | $0.6B | $0.8B | $0.3B | $0.7B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.1B | $-0.0B | $-0.3B | $-0.5B | $-3.5B | $-0.2B | $-2.7B | $-0.0B |
| Capital Expenditures | $0.1B | $0.1B | $0.3B | $0.4B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $0.0B | $-0.6B | $-0.4B | $-0.5B | $2.6B | $0.1B | $1.1B | $0.7B |